Navigation Links
Research on China's Animal Vaccine Industry, 2013-2017
Date:1/29/2013

NEW YORK, Jan. 29, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Research on China's Animal Vaccine Industry, 2013-2017

http://www.reportlinker.com/p01084128/Research-on-China's-Animal-Vaccine-Industry-2013-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

Animal vaccine sales amount in China was about CNY 7.11 billion (excluding net imports); the sales amount of swine vaccine and poultry vaccines were CNY 3.51 billion and 3.01 billion respectively, accounting for 49.4% and 42.3% of the total sales amount respectively. The market scale of China's animal vaccine is nearly CNY 10 billion in 2012.

Although there are nearly 60 animal vaccine manufacturers in China, the market share is concentrated in the hands of a few corporations. CAHIC, Qingdao Yebio Bioengineering Co. Ltd., Dahuanong, TECON and Chengdu TECBOND are the representatives of China's animal vaccine industry. The five enterprises accounted for 37.9% of China's animal vaccine market in the first half of 2012.

Among the key animal vaccine manufacturers in China, China Animal Husbandry Industry Co., Ltd (CAHIC) obtained the highest business income in the first half of 2012—CNY 964 million, accounting for 14.3% market share. TECON, Dahuanong and Jinyu Group also had more than 5% market share respectively. The sales of these companies mainly came from the national mandatory vaccine procurement policy. The proportion of the national mandatory vaccine procurement accounted for 82.7% of CAHIC's total income in the first half of 2012.

In recent years, animal mandatory immunization coverage is gradually expanded in China. Restricted by the economic conditions, compulsory vaccination epidemics only cover five kinds of animal disease. While there are about 17 kinds of animal diseases; other diseases also have great hazard. With farming enterprises and farmers enhanced emphasis on the prevention and control of animal diseases, the demand of conventional vaccine at their own expense will be further improved in the future. Swine and poultry are the main species in China's livestock breeding, newcastle disease vaccine and porcine circovirus vaccine will be the two conventional vaccines with very good market prospects. 1. Development Environment of China's Animal Vaccine Industry1.1 Market Characteristics1.1.1 Industry Definition1.1.2 Industry Characteristics1.2 Economic Environment1.2.1 Economic Development Status1.2.2 GDP1.2.3 Fixed Asset Investment1.2.4 Import and Export Amount and Growth Rate1.3 Policy Environment1.3.1 Industry Related Policy1.3.2 Effect of Related Policy

2. Technology Development of China's Animal Vaccine Industry

2.1 Product Technology Maturity

2.2 Technology Gap between China and Foreign Countries and Main Reasons

2.3 Strategy for Improving China's Technology

3. Development of China's Animal Vaccine Industry3.1 Swine Vaccine3.2 Poultry Vaccines3.3 Pet Vaccines

4. Economic Operation of Animal Vaccine Industry

4.1 Industry Production and Sales, 2007-2012

4.2 Industry Scale, 2007-2012

4.3 Industry Profitability in 2011

4.4 Industry Business Development Capacity in 2011

4.5 Industry Debt Paying Ability in 2011

5. Import and Export of China's Animal Vaccine5.1 Import5.2 Export

6. Effect of Industry Competition Landscape on Investment in China, 2012

6.1 Michael Porter Five Forces Analysis of China's Animal Vaccine Industry

6.1.1 Competition between the Existing Enterprises

6.1.2 Potential New Entrant

6.1.3 Substitute

6.1.4 Bargaining Power of Supplier

6.1.5 Bargaining Power of Customers

6.2 Competition Landscape of China's Animal Vaccine Industry

6.3 Competition Forecast of China's Animal Vaccine Industry

7. Domestic Key Enterprises, 2011-20127.1 China Animal Husbandry Industry Co., Ltd. (CAHIC)7.1.1 Company Profile7.1.2 Business Performance7.1.3 Company Competitiveness7.1.4 Development Strategy7.2 Inner Mongolia Jinyu Group Stock Company7.2.1 Company Profile7.2.2 Business Performance7.2.3 Company Competitiveness7.2.4 Development Strategy7.3 TECON 7.3.1 Company Profile7.3.2 Business Performance7.3.3 Company Competitiveness7.3.4 Development Strategy7.4 Chengdu TECBOND Biological Products Co. Ltd.7.4.1 Company Profile7.4.2 Business Performance7.4.3 Company Competitiveness7.4.4 Development Strategy7.5 Guangdong Dahuanong Animal Health Products Co. Ltd.7.5.1 Company Profile7.5.2 Business Performance7.5.3 Company Competitiveness7.5.4 Development Strategy

8. Investment Analysis of Animal Vaccine Industry, 2013-2017

8.1 Investment Opportunity

8.2 Investment Risk

8.2.1 Policy Risk

8.2.2 Market Risk

8.2.3 Application Risk

8.2.4 Technology Risk

8.3 Industry Barriers to Entry

8.3.1 Administrative Barriers to Entry

8.3.2 Technical Barrier

8.3.3 Brand Barrier

8.3.4 Management Barrier

8.3.5 Financial Barrier

8.4 Industry Investment Proposals

9. Investment Opportunity and Risk of Animal Vaccine Industry9.1 Investment Opportunity of China's Animal Vaccine Industry9.1.1 Investment Opportunity9.1.2 Feasibility Study9.2 Investment Efficiency of Animal Vaccine Industry9.2.1 Investment Status in 20129.2.2 Investment Efficiency in 20129.2.3 Investment Trend Forecast 2013-20179.2.4 Investment Orientation, 2013-2017

Companies Mentioned China Animal Husbandry Industry Co., Ltd. (CAHIC)

Inner Mongolia Jinyu Group Stock Company

TECON

Chengdu TECBOND Biological Products Co. Ltd.

Guangdong Dahuanong Animal Health Products Co. Ltd.

To order this report:: Research on China's Animal Vaccine Industry, 2013-2017

Nicolas Bombourg

Reportlinker

Email: nicolasbombourg@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Army Researcher Develops Potential Vaccine Carrier That May Give Stockpiling Efforts A Shot In The Arm
2. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
3. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
4. Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
5. Galenea to Receive $6 Million From The Stanley Medical Research Institute to Progress Pro-Cognitive Drug Discovery and Development Program
6. Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate
7. Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
8. ResearchMoz: The World Anesthesia Drug Market (General, Local, Adjunctive) - Market Research Report
9. Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism
10. ResearchMoz: Telemedicine Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 - Market Research Report
11. Okuma America Chooses The Daniel Group To Provide Customer Service Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... PUNE, India , June 24, 2016 ... "Pen Needles Market by Type (Standard Pen Needles, Safety ... 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase ... published by MarketsandMarkets, This report studies the market for ... is expected to reach USD 2.81 Billion by 2021 ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... - Forecast to 2022" report to their offering. ... to date financial data derived from varied research sources to ... potential impact on the market during the next five years, ... of sub markets, regional and country level analysis. The report ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating ... many ways they remain in the eye of the beholder, according to experts who ... of The American Journal of Managed Care. For the full issue, click here ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from ... at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center ... care topics including advance care planning, healthcare costs and patient and family engagement. ...
(Date:6/25/2016)... ... 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can ... CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn ... X . Simply select a ProHand generator and drag it above media or text ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
Breaking Medicine News(10 mins):